1 / 31

LEUKEMIA

LEUKEMIA. ↑ leukocytes Acute leukemias 1. Acute Lymphoblastic Leukemia (ALL) 2. Acute Myelogenous Leukemia (AML). Chronic leukemias 1.Chronic L ymphoblastic Leukemia (CLL) 2. Chronic Myelogenous Leukemia (CML). Leukemias. Acute Leukemias. Blast predominate Child or elder

jola
Download Presentation

LEUKEMIA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LEUKEMIA

  2. ↑ leukocytes Acute leukemias 1. Acute Lymphoblastic Leukemia (ALL) 2. Acute Myelogenous Leukemia (AML) Chronic leukemias 1.Chronic Lymphoblastic Leukemia (CLL) 2. Chronic Myelogenous Leukemia (CML) Leukemias

  3. Acute Leukemias • Blast predominate • Child or elder • Short & drastic course • ALL – Lymphoblasts (pre-B or pre-T) • AML – Myeloblasts

  4. Chronic Leukemias • More mature cells • Middle age • Longer & less devastating course • CLL – Lymphocytes • CML – Myeloid stem cells

  5. Acute Leukemias • accumulation of blasts in the marrow

  6. Acute Lymphoblastic Leukemia (ALL) • Children • Lymphoblasts (pre-B or pre-T) • Neoplastic transformation of the lymphoid stem cells • Progressive accumulation of Lymphoblasts in the bone marrow • Suppression of normal hemopoiesis

  7. ALL

  8. • Primarily a disease of children and young adults • B-cell subtype (80%) • T-cell subtype (20%)

  9. ALL Abrupt onset Signs and symptoms related to: • Suppression of normal hemopoiesis bone pain and tenderness • Tissue infiltration ( megaly) (lymph nodes, spleen, liver, testicles, CNS) • Mediastinal mass ( T-ALL ) thymus involvement Headache, vomiting, nerve palsies from meningeal spread.

  10. Signs &Symptoms • Anemia • Infection • Bleeding • Bone pain • Arthritis • Splenomegaly • Lymphadenopathy • CNS involvement

  11. ALL - PROGNOSIS Favorable: Unfavorable: Pre-B T or mature B Age 3-7 < 1, > 10 WBC < 10 000/uL > 50 000/uL Female Male Minimal organ Prominent organ involvement involvement

  12. ALL Prognosis: • Age 3-7, pre-B, > 90% - CR( 2/3 - cure ) • Adults, mature B and T-ALL: Less favorable Therapy: Chemotherapy supportive care, BMT

  13. ACUTEMYELOGENOUS LEUKEMIA ( AML ) • Adults • Myeloblasts • monoblasts, eosinoblasts, megakarioblasts, proerythroblasts, basophiloblasts • Auer rods in the cytoplasm of the cells • Very rapidly progressive malignancy

  14. AML

  15. Auer rods in AML

  16. Differentiation from ALL may be made by microscopy – presence of Auer Rods. • Can also be made based on immunotyping and molecular methods. Clinical features based on • Marrow failure –anemia, bleeding, DIC, infection… • Leukemic infiltration – bone pain, CNS signs, hepatosplenomegaly, lymphadenopathy… • Constitutional upset -- malaise, fever, weakness, polyarthritis.

  17. Course: • Rapidly fatal if untreated (< 2 mo ) • Median survival - 3 years after chem.. • Adverse prognostic factors: Age > 60 Previous chemotherapy Leukocytosis > 100,000 /ul Therapy:Chemotherapy, supportive, BMT

  18. ***Remember this*** For Acute leukemias • acute leukemias = too many blasts in the marrow • 2 broad categories: AML vs. ALL • a hematologic urgency • prognosis is poor in adults; but good in kids with ALL.

  19. CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) A monoclonal lymphoproliferative disorder characterized by lymphocytosis(>4000/cu.mm), lymphadenopathy and splenomegaly B - CLL > 95% T - CLL

  20. CLL •Most common adult leukemia in Western society (30% of all leukemias) • Monoclonal proliferation of the small lymphocytes… • Age > 40 M:F / 2:1

  21. CLL - Pathology Blood: • Lymphocytosis ( > 10,000 u/L - diagnostic ) • (+) Coombs test (20%) • Hypogammaglobulinemia (50-70%) • Anemia, thrombocytopenia, neutropenia Bone marrow: • nodular / interstitial infiltrates • diffuse - obliteration of normal hemopoiesis Lymphadenopathy,Hepatosplenomegaly(50-60%)

  22. CLL - Clinical course Initially: asymptomatic Advanced disease: • bacterial infections, hemorrhage Prognostic factors: • extent of tumor burden • pattern of marrow infiltration • chromosomal abnormalities Median survival: ~ 6 years

  23. CLL - Course • CONVERSION TO PROLYMPHOCYTIC LEUKEMIA (10%) • RICHTER SYNDROME (5%)(AGGRESSIVE LYMPHOMA) • DEATH OFTEN DUE TO INFECTIONS..

  24. Smudge cells - CLL

  25. CLL • One more peripheral blood findings in CLL is Presence of Smudge cells ( parachute cells). • Along with increased number of normal appearing lymphocytes.

  26. mainly uncontrolled proliferation of myeloid cells. • Males more than females • Splenomegaly – sometimes massive..

  27. **Philadelphia chromosome** • Hybrid chromosome with translocation between the long arm of chr. 9 and long arm of chr.22 . --- t(9:22). • May be present in granulocyte, RBC or platelet precursors in more than 95% of CML.. • Absence of these chr. may have worse prognosis.

  28. CML - Clinical Features 15 - 20% of all leukemias; age 25-60 Symptoms: - non-specific - related to hypermetabolism (high cell turnover) - related to splenomegaly Course: - chronic phase (mean survival, 3-4y) - accelerated phase - blast crisis / myeloid or lymphoid (survival, < 1y) Therapy: chemotherapy; BMT

  29. CML: Sustained granulocytosis with immature cells; low LAP score; bone marrow pathology; Philadelphia chromosome • LAP – leukocyte alkaline phosphatase

More Related